Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus | 22 | 2019 | 411 | 3.690 |
Why?
|
| Diabetes Mellitus, Type 2 | 18 | 2019 | 1428 | 2.600 |
Why?
|
| Clinical Competence | 5 | 2019 | 333 | 1.620 |
Why?
|
| Blood Glucose Self-Monitoring | 6 | 2013 | 27 | 1.570 |
Why?
|
| Family Practice | 5 | 2020 | 51 | 1.550 |
Why?
|
| Curriculum | 3 | 2018 | 213 | 1.290 |
Why?
|
| Blood Glucose | 8 | 2013 | 492 | 1.250 |
Why?
|
| Health Literacy | 4 | 2018 | 28 | 1.210 |
Why?
|
| Patient Education as Topic | 6 | 2018 | 271 | 1.170 |
Why?
|
| Health Knowledge, Attitudes, Practice | 7 | 2019 | 353 | 1.170 |
Why?
|
| Attitude to Health | 3 | 2020 | 165 | 1.080 |
Why?
|
| Self Care | 8 | 2016 | 144 | 1.080 |
Why?
|
| European Continental Ancestry Group | 11 | 2014 | 1169 | 1.010 |
Why?
|
| Hypertension | 4 | 2017 | 957 | 0.980 |
Why?
|
| Humans | 57 | 2021 | 32025 | 0.980 |
Why?
|
| Primary Health Care | 4 | 2021 | 227 | 0.960 |
Why?
|
| Antihypertensive Agents | 2 | 2017 | 351 | 0.950 |
Why?
|
| Female | 41 | 2020 | 19954 | 0.930 |
Why?
|
| Middle Aged | 32 | 2021 | 11868 | 0.820 |
Why?
|
| Hypoglycemic Agents | 4 | 2010 | 181 | 0.810 |
Why?
|
| Patient-Centered Care | 2 | 2016 | 75 | 0.810 |
Why?
|
| Male | 36 | 2020 | 19196 | 0.770 |
Why?
|
| Naloxone | 1 | 2021 | 26 | 0.750 |
Why?
|
| Students, Medical | 3 | 2019 | 131 | 0.740 |
Why?
|
| Mental Health Services | 1 | 2020 | 28 | 0.720 |
Why?
|
| Ethnic Groups | 5 | 2016 | 476 | 0.700 |
Why?
|
| Aged | 28 | 2020 | 10340 | 0.690 |
Why?
|
| Obstetrics | 1 | 2019 | 26 | 0.670 |
Why?
|
| Pharmacists | 2 | 2017 | 20 | 0.670 |
Why?
|
| Islam | 1 | 2019 | 2 | 0.670 |
Why?
|
| Arabs | 1 | 2019 | 4 | 0.670 |
Why?
|
| Refugees | 1 | 2019 | 7 | 0.660 |
Why?
|
| Maternal Health Services | 1 | 2019 | 8 | 0.660 |
Why?
|
| Diabetic Neuropathies | 1 | 2019 | 24 | 0.660 |
Why?
|
| African Americans | 9 | 2014 | 1428 | 0.640 |
Why?
|
| Patient Compliance | 5 | 2013 | 224 | 0.640 |
Why?
|
| Neuralgia | 1 | 2019 | 48 | 0.640 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 240 | 0.640 |
Why?
|
| Health Behavior | 5 | 2014 | 231 | 0.640 |
Why?
|
| Adult | 16 | 2020 | 9367 | 0.630 |
Why?
|
| Group Processes | 1 | 2018 | 15 | 0.610 |
Why?
|
| Education, Pharmacy, Continuing | 1 | 2017 | 2 | 0.590 |
Why?
|
| Diabetes, Gestational | 2 | 2009 | 24 | 0.590 |
Why?
|
| Cardiovascular Diseases | 5 | 2016 | 1125 | 0.590 |
Why?
|
| Education, Medical, Continuing | 2 | 2008 | 55 | 0.590 |
Why?
|
| Program Development | 1 | 2017 | 96 | 0.570 |
Why?
|
| North Carolina | 12 | 2019 | 1516 | 0.560 |
Why?
|
| Aged, 80 and over | 16 | 2020 | 4000 | 0.560 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 242 | 0.560 |
Why?
|
| Anticoagulants | 1 | 2017 | 123 | 0.540 |
Why?
|
| Prenatal Care | 1 | 2016 | 51 | 0.540 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2017 | 188 | 0.530 |
Why?
|
| Insulin | 2 | 2010 | 366 | 0.530 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 217 | 0.530 |
Why?
|
| Patient Participation | 1 | 2016 | 82 | 0.530 |
Why?
|
| Cross-Sectional Studies | 12 | 2014 | 1530 | 0.520 |
Why?
|
| Practice Guidelines as Topic | 3 | 2017 | 407 | 0.500 |
Why?
|
| Blood Pressure | 5 | 2017 | 845 | 0.490 |
Why?
|
| Diabetic Angiopathies | 2 | 2013 | 143 | 0.480 |
Why?
|
| Rural Population | 8 | 2014 | 273 | 0.470 |
Why?
|
| Cultural Characteristics | 1 | 2014 | 16 | 0.460 |
Why?
|
| Students, Health Occupations | 1 | 2013 | 8 | 0.430 |
Why?
|
| Dietary Fats | 1 | 2013 | 111 | 0.420 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2018 | 87 | 0.420 |
Why?
|
| Counseling | 1 | 2013 | 97 | 0.410 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2011 | 3 | 0.400 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2014 | 168 | 0.400 |
Why?
|
| Pregnancy | 4 | 2019 | 994 | 0.360 |
Why?
|
| Cohort Studies | 6 | 2020 | 1831 | 0.360 |
Why?
|
| Hyperglycemia | 1 | 2010 | 85 | 0.350 |
Why?
|
| United States | 9 | 2014 | 3938 | 0.340 |
Why?
|
| Risk Factors | 11 | 2017 | 3869 | 0.340 |
Why?
|
| Academic Medical Centers | 2 | 2008 | 160 | 0.330 |
Why?
|
| Qualitative Research | 5 | 2019 | 166 | 0.330 |
Why?
|
| Research Design | 2 | 2008 | 312 | 0.330 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2008 | 5 | 0.310 |
Why?
|
| Disease Management | 3 | 2014 | 126 | 0.310 |
Why?
|
| Minority Groups | 3 | 2016 | 76 | 0.310 |
Why?
|
| Dietary Carbohydrates | 1 | 2008 | 22 | 0.310 |
Why?
|
| Faculty, Medical | 1 | 2008 | 78 | 0.290 |
Why?
|
| Ambulatory Care | 2 | 2018 | 108 | 0.280 |
Why?
|
| Education, Medical, Graduate | 1 | 2007 | 129 | 0.270 |
Why?
|
| Indians, North American | 6 | 2013 | 109 | 0.270 |
Why?
|
| Coronary Disease | 1 | 2007 | 213 | 0.270 |
Why?
|
| Hyperlipidemias | 2 | 2005 | 54 | 0.270 |
Why?
|
| Hispanic Americans | 3 | 2007 | 942 | 0.240 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 173 | 0.240 |
Why?
|
| Mass Screening | 2 | 2009 | 264 | 0.240 |
Why?
|
| Physician-Patient Relations | 2 | 2018 | 185 | 0.230 |
Why?
|
| Obesity | 3 | 2016 | 1179 | 0.230 |
Why?
|
| Exercise | 3 | 2016 | 672 | 0.220 |
Why?
|
| Socioeconomic Factors | 3 | 2014 | 420 | 0.220 |
Why?
|
| Absorptiometry, Photon | 1 | 2002 | 143 | 0.200 |
Why?
|
| Reproducibility of Results | 3 | 2013 | 765 | 0.200 |
Why?
|
| Osteoporosis | 1 | 2002 | 69 | 0.190 |
Why?
|
| Harm Reduction | 1 | 2021 | 14 | 0.190 |
Why?
|
| Narcotic Antagonists | 1 | 2021 | 39 | 0.190 |
Why?
|
| Serbia | 1 | 2019 | 4 | 0.180 |
Why?
|
| Age Factors | 4 | 2013 | 1194 | 0.170 |
Why?
|
| Physician Assistants | 2 | 2013 | 41 | 0.170 |
Why?
|
| Appointments and Schedules | 1 | 2019 | 22 | 0.170 |
Why?
|
| Prospective Studies | 2 | 2021 | 2283 | 0.170 |
Why?
|
| Risk Reduction Behavior | 2 | 2016 | 125 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2011 | 507 | 0.160 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 159 | 0.160 |
Why?
|
| Education, Medical | 1 | 2019 | 69 | 0.160 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 231 | 0.160 |
Why?
|
| Adaptation, Psychological | 1 | 2019 | 136 | 0.150 |
Why?
|
| South Carolina | 1 | 2017 | 31 | 0.150 |
Why?
|
| Clinical Clerkship | 1 | 2018 | 42 | 0.150 |
Why?
|
| Tennessee | 1 | 2017 | 101 | 0.150 |
Why?
|
| Certification | 1 | 2017 | 27 | 0.140 |
Why?
|
| Frail Elderly | 1 | 2017 | 69 | 0.140 |
Why?
|
| Group Practice | 1 | 2016 | 3 | 0.140 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 900 | 0.140 |
Why?
|
| Administration, Cutaneous | 1 | 2017 | 116 | 0.140 |
Why?
|
| Models, Organizational | 1 | 2016 | 15 | 0.140 |
Why?
|
| Adolescent | 2 | 2020 | 3526 | 0.140 |
Why?
|
| Communication | 1 | 2018 | 140 | 0.140 |
Why?
|
| Young Adult | 2 | 2020 | 2615 | 0.130 |
Why?
|
| Sex Factors | 3 | 2013 | 663 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 629 | 0.130 |
Why?
|
| Caloric Restriction | 1 | 2016 | 106 | 0.130 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 300 | 0.130 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 771 | 0.130 |
Why?
|
| African Continental Ancestry Group | 2 | 2007 | 363 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2016 | 162 | 0.120 |
Why?
|
| Culture | 2 | 2012 | 41 | 0.120 |
Why?
|
| Patient Selection | 1 | 2016 | 277 | 0.120 |
Why?
|
| Linear Models | 2 | 2013 | 449 | 0.120 |
Why?
|
| Diabetes Complications | 2 | 2013 | 177 | 0.120 |
Why?
|
| Executive Function | 2 | 2012 | 57 | 0.110 |
Why?
|
| Fear | 1 | 2013 | 48 | 0.110 |
Why?
|
| Trust | 1 | 2013 | 43 | 0.110 |
Why?
|
| Faculty | 1 | 2013 | 17 | 0.110 |
Why?
|
| Patient Simulation | 1 | 2013 | 32 | 0.110 |
Why?
|
| Feedback | 1 | 2013 | 43 | 0.110 |
Why?
|
| Energy Intake | 1 | 2013 | 128 | 0.100 |
Why?
|
| Weight Gain | 1 | 2013 | 118 | 0.100 |
Why?
|
| Program Evaluation | 1 | 2013 | 186 | 0.100 |
Why?
|
| Social Control, Informal | 1 | 2012 | 8 | 0.100 |
Why?
|
| Interpersonal Relations | 1 | 2012 | 57 | 0.100 |
Why?
|
| Cognition | 2 | 2013 | 553 | 0.100 |
Why?
|
| Placebos | 1 | 2011 | 63 | 0.100 |
Why?
|
| Glycemic Index | 1 | 2011 | 14 | 0.100 |
Why?
|
| Lipoproteins, LDL | 1 | 2011 | 81 | 0.100 |
Why?
|
| Narration | 1 | 2011 | 18 | 0.100 |
Why?
|
| Body Weight | 1 | 2013 | 310 | 0.090 |
Why?
|
| Interviews as Topic | 4 | 2013 | 263 | 0.090 |
Why?
|
| Insurance Coverage | 1 | 2011 | 75 | 0.090 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2010 | 9 | 0.090 |
Why?
|
| Motor Activity | 1 | 2013 | 325 | 0.090 |
Why?
|
| Professional Role | 1 | 2010 | 19 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 47 | 0.090 |
Why?
|
| Chi-Square Distribution | 2 | 2007 | 298 | 0.090 |
Why?
|
| Documentation | 1 | 2010 | 46 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2013 | 923 | 0.090 |
Why?
|
| Asian Americans | 2 | 2007 | 97 | 0.080 |
Why?
|
| Choice Behavior | 1 | 2010 | 87 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 251 | 0.080 |
Why?
|
| Staff Development | 1 | 2008 | 16 | 0.080 |
Why?
|
| Geography | 1 | 2007 | 34 | 0.080 |
Why?
|
| Models, Educational | 1 | 2007 | 20 | 0.070 |
Why?
|
| Safety | 1 | 2008 | 78 | 0.070 |
Why?
|
| Life Style | 1 | 2010 | 408 | 0.070 |
Why?
|
| Mexican Americans | 1 | 2007 | 60 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2008 | 104 | 0.070 |
Why?
|
| Hospitalization | 1 | 2010 | 470 | 0.070 |
Why?
|
| Information Systems | 1 | 2006 | 10 | 0.070 |
Why?
|
| Nutrition Surveys | 1 | 2007 | 148 | 0.070 |
Why?
|
| Insulin, Long-Acting | 1 | 2006 | 3 | 0.070 |
Why?
|
| Logistic Models | 2 | 2012 | 781 | 0.070 |
Why?
|
| Odds Ratio | 1 | 2007 | 474 | 0.060 |
Why?
|
| Pregnancy Outcome | 1 | 2006 | 90 | 0.060 |
Why?
|
| Social Justice | 1 | 2005 | 17 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2016 | 3317 | 0.060 |
Why?
|
| Quality Indicators, Health Care | 1 | 2005 | 59 | 0.060 |
Why?
|
| Quality of Life | 2 | 2016 | 933 | 0.060 |
Why?
|
| Lipids | 1 | 2005 | 229 | 0.060 |
Why?
|
| Minerals | 1 | 2003 | 14 | 0.060 |
Why?
|
| Medicare | 1 | 2004 | 207 | 0.050 |
Why?
|
| Vitamins | 1 | 2003 | 68 | 0.050 |
Why?
|
| Child | 1 | 2009 | 2441 | 0.050 |
Why?
|
| Heel | 1 | 2002 | 6 | 0.050 |
Why?
|
| Alendronate | 1 | 2002 | 11 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2003 | 188 | 0.050 |
Why?
|
| Bone Density | 1 | 2002 | 203 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2005 | 1435 | 0.040 |
Why?
|
| Geriatric Assessment | 2 | 2012 | 391 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2019 | 186 | 0.040 |
Why?
|
| Depression | 2 | 2012 | 443 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2005 | 3523 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2019 | 218 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2016 | 31 | 0.040 |
Why?
|
| Community Health Services | 1 | 2016 | 56 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 186 | 0.030 |
Why?
|
| Poverty | 1 | 2016 | 111 | 0.030 |
Why?
|
| Overweight | 1 | 2016 | 279 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2005 | 488 | 0.030 |
Why?
|
| Medicine | 1 | 2013 | 38 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2013 | 43 | 0.030 |
Why?
|
| Weight Loss | 1 | 2016 | 480 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2005 | 757 | 0.030 |
Why?
|
| Family Relations | 1 | 2012 | 23 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2012 | 97 | 0.030 |
Why?
|
| Cross-Cultural Comparison | 1 | 2012 | 26 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2013 | 155 | 0.030 |
Why?
|
| Disabled Persons | 1 | 2012 | 105 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2012 | 77 | 0.020 |
Why?
|
| Holistic Health | 1 | 2011 | 7 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 294 | 0.020 |
Why?
|
| Educational Status | 1 | 2012 | 179 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 2152 | 0.020 |
Why?
|
| Social Support | 1 | 2012 | 179 | 0.020 |
Why?
|
| Health Status | 1 | 2013 | 399 | 0.020 |
Why?
|
| Incidence | 2 | 2005 | 1200 | 0.020 |
Why?
|
| Social Environment | 1 | 2011 | 79 | 0.020 |
Why?
|
| Continental Population Groups | 1 | 2012 | 237 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2011 | 136 | 0.020 |
Why?
|
| Southeastern United States | 1 | 2005 | 79 | 0.020 |
Why?
|
| Morbidity | 1 | 2005 | 99 | 0.020 |
Why?
|
| Aging | 1 | 2012 | 945 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 401 | 0.010 |
Why?
|
| Infection Control | 1 | 2003 | 28 | 0.010 |
Why?
|
| Prevalence | 1 | 2005 | 981 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2003 | 75 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2003 | 526 | 0.010 |
Why?
|